by Ryan Paolicelli | Jan 17, 2024
Jennifer Young is Vice President, Global Policy and Public Affairs for Specialty Care, Policy Planning, and Strategy at Pfizer. Jennifer leads diverse global teams including Pfizer’s Global Policy and Public Affairs (GPPA) Specialty Care team overseeing development...
by Ryan Paolicelli | Feb 23, 2023
Nácia Pupo Taylor leads initiatives focused on health systems sustainability, global health security, anti-microbial resistance, emerging infectious diseases, and vaccines. Nácia is passionate about improving healthcare for everyone, everywhere and a strong believer...
by Ryan Paolicelli | Feb 23, 2023
Michael Lobritz is the Head of Infectious Diseases Early Development at F. Hoffmann-La Roche, Ltd, based in Basel, Switzerland. His group is responsible for the translational development of Roche antibiotics and antivirals from Phase 0 through Phase 2, including the...
by Ryan Paolicelli | Feb 23, 2023
Currently, Global Therapeutic Area Head for Infectious Diseases at Menarini Group. His over 25 years’ experience and expertise in Pharma covers various disease fields including CNS, Gastroenterology, Bone diseases, oncology and infectious disease including vaccines...
by Ryan Paolicelli | Feb 23, 2023
Greg Frank serves as Director of Global Public Policy for MSD.
